Low-Dose Nutrient Mix Shows Promise in Treating Autism Behaviors in Mice

A new study has found that a low-dose mixture of zinc, serine, and branch-chain amino acids (BCAAs) can improve social behaviours in mouse models of autism spectrum disorder (ASD). Researchers suggest this approach could offer a safer, more practical treatment than targeting single genes—given that hundreds are linked to the condition. The findings point to a potential alternative for managing behavioural deficits in ASD without high-dose interventions. Autism spectrum disorder is marked by difficulties in social interaction, communication challenges, and repetitive behaviours. It arises from abnormal neural development, where connections between neurons are disrupted. While nutrition is known to influence these processes, previous research on dietary interventions—such as the gluten-free, casein-free (GFCF) diet—has produced inconsistent results in humans.

In this study, scientists tested a cocktail of zinc, serine, and BCAAs on three different mouse models of ASD. When given separately, none of the supplements had a noticeable effect. However, when combined, the mixture improved social behaviours and reduced abnormal neuron hyperactivity in the amygdala—a brain region linked to emotional processing. The treated mice showed brain activity patterns closer to those of normal mice. The researchers also observed similar improvements in two other ASD mouse models, _Nf1_ and _Cttnbp2_. They proposed that this combination works by enhancing communication between neurons. Importantly, the low-dose approach could minimise side effects while remaining effective over long-term use.

The study highlights a potential new strategy for ASD treatment, using a nutrient mixture rather than high-dose single supplements. By targeting multiple pathways at once, the approach may address the complexity of autism more effectively. Further research will be needed to determine whether these findings translate to humans with ASD.